• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活的 CARD11 加速生发中心动力学,促进 mTORC1 和终末分化。

Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation.

机构信息

Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.

Department of Immunology, University of Washington School of Medicine, Seattle, WA.

出版信息

J Exp Med. 2018 Sep 3;215(9):2445-2461. doi: 10.1084/jem.20180230. Epub 2018 Aug 20.

DOI:10.1084/jem.20180230
PMID:30127060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6122963/
Abstract

Activating mutations in the adapter protein CARD11 associated with diffuse large B cell lymphomas (DLBCLs) are predicted to arise during germinal center (GC) responses, leading to inappropriate activation of NF-κB signaling. Here, we modeled the B cell-intrinsic impact of the L251P activating mutation in CARD11 (aCARD11) on the GC response. Global B cell aCARD11 expression led to a modest increase in splenic B cells and a severe reduction in B1 B cell numbers, respectively. Following T cell-dependent immunization, aCARD11 cells exhibited increased rates of GC formation, resolution, and differentiation. Restriction of aCARD11 to GC B cells similarly altered the GC response and B cell differentiation. In this model, aCARD11 promoted dark zone skewing along with increased cycling, AID levels, and class switch recombination. Furthermore, aCard11 GC B cells displayed increased biomass and mTORC1 signaling, suggesting a novel strategy for targeting aCARD11-driven DLBCL. While aCARD11 potently impacts GC responses, the rapid GC contraction suggests it requires collaboration with events that limit terminal differentiation to promote lymphoma.

摘要

与弥漫性大 B 细胞淋巴瘤(DLBCLs)相关的衔接蛋白 CARD11 的激活突变预计在生发中心(GC)反应中产生,导致 NF-κB 信号的异常激活。在这里,我们模拟了 CARD11(aCARD11)中的 L251P 激活突变对 GC 反应的内在 B 细胞影响。全局 B 细胞 aCARD11 表达分别导致脾脏 B 细胞适度增加和 B1 B 细胞数量严重减少。在 T 细胞依赖性免疫接种后,aCARD11 细胞表现出 GC 形成、解决和分化的增加率。将 aCARD11 限制在 GC B 细胞中同样改变了 GC 反应和 B 细胞分化。在该模型中,aCARD11 促进暗区偏斜,同时增加循环、AID 水平和类别转换重组。此外,aCard11 GC B 细胞显示出增加的生物量和 mTORC1 信号,表明针对 aCARD11 驱动的 DLBCL 的一种新策略。虽然 aCARD11 强烈影响 GC 反应,但快速的 GC 收缩表明它需要与限制终末分化以促进淋巴瘤的事件协作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/672c211e9684/JEM_20180230_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/16e2e93646f4/JEM_20180230_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/77be8ddd34df/JEM_20180230_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/02780c4fb349/JEM_20180230_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/7007b969c540/JEM_20180230_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/a626deaa1f2c/JEM_20180230_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/6a94dd011d3b/JEM_20180230_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/672c211e9684/JEM_20180230_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/16e2e93646f4/JEM_20180230_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/77be8ddd34df/JEM_20180230_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/02780c4fb349/JEM_20180230_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/7007b969c540/JEM_20180230_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/a626deaa1f2c/JEM_20180230_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/6a94dd011d3b/JEM_20180230_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44b4/6122963/672c211e9684/JEM_20180230_Fig7.jpg

相似文献

1
Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation.激活的 CARD11 加速生发中心动力学,促进 mTORC1 和终末分化。
J Exp Med. 2018 Sep 3;215(9):2445-2461. doi: 10.1084/jem.20180230. Epub 2018 Aug 20.
2
B Cell-Intrinsic mTORC1 Promotes Germinal Center-Defining Transcription Factor Gene Expression, Somatic Hypermutation, and Memory B Cell Generation in Humoral Immunity.B 细胞内在的 mTORC1 促进生发中心定义转录因子基因表达、体细胞超突变和体液免疫中的记忆 B 细胞生成。
J Immunol. 2018 Apr 15;200(8):2627-2639. doi: 10.4049/jimmunol.1701321. Epub 2018 Mar 12.
3
M17, a gene specific for germinal center (GC) B cells and a prognostic marker for GC B-cell lymphomas, is dispensable for the GC reaction in mice.M17是生发中心(GC)B细胞特有的基因,也是GC B细胞淋巴瘤的预后标志物,在小鼠的GC反应中并非必需。
Blood. 2006 Jun 15;107(12):4849-56. doi: 10.1182/blood-2005-10-4154. Epub 2006 Feb 21.
4
MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.MYD88、CARD11和CD79B致癌突变在印度初发性淋巴结弥漫性大B细胞淋巴瘤队列中是罕见事件。
Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):311-318. doi: 10.1097/PAI.0000000000000585.
5
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.适应性 T 细胞免疫控制易发生衰老的 MyD88 或 CARD11 突变 B 细胞淋巴瘤。
Blood. 2021 May 20;137(20):2785-2799. doi: 10.1182/blood.2020005244.
6
Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.CREBBP 的失活会扩增生发中心 B 细胞区室,下调 MHCII 的表达,并促进 DLBCL 的生长。
Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):9701-9706. doi: 10.1073/pnas.1619555114. Epub 2017 Aug 22.
7
Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and mTORC1 Activity in Germinal Center B Lymphocytes.与Toll样受体9激动剂复合的抗原增强生发中心B淋巴细胞中的c-Myc和雷帕霉素靶蛋白复合物1(mTORC1)活性。
Immunohorizons. 2019 Aug 19;3(8):389-401. doi: 10.4049/immunohorizons.1900030.
8
Cooperative Control of Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling by an Unusual Array of Redundant Repressive Elements.通过一系列不同寻常的冗余抑制元件对含半胱天冬酶募集结构域蛋白11(CARD11)信号传导的协同控制
J Biol Chem. 2016 Apr 15;291(16):8324-36. doi: 10.1074/jbc.M115.683714. Epub 2016 Feb 16.
9
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.Smc3 剂量调节 B 细胞通过生发中心的转运,并限制其恶性转化。
Nat Immunol. 2021 Feb;22(2):240-253. doi: 10.1038/s41590-020-00827-8. Epub 2021 Jan 11.
10
miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.微小RNA-28在非霍奇金淋巴瘤的临床前模型中调节生发中心反应并抑制肿瘤生长。
Blood. 2017 Apr 27;129(17):2408-2419. doi: 10.1182/blood-2016-08-731166. Epub 2017 Feb 10.

引用本文的文献

1
Successful Treatment with Sirolimus of a Patient with a Novel CARD11 Germline Mutation in B-Cell Expansion with Nuclear Factor Kappa B and T-Cell Anergy: Case Report and Literature Review.西罗莫司成功治疗一例具有新型CARD11种系突变的患者:核因子κB介导的B细胞扩增及T细胞无能的病例报告与文献综述
J Clin Immunol. 2025 Feb 25;45(1):78. doi: 10.1007/s10875-025-01872-4.
2
CARD11 regulates the thymic Treg development in an NF-κB-independent manner.CARD11 通过非 NF-κB 依赖的方式调节胸腺 Treg 的发育。
Front Immunol. 2024 Apr 8;15:1364957. doi: 10.3389/fimmu.2024.1364957. eCollection 2024.
3
gain-of-function mutation drives cell-autonomous accumulation of PD-1 ICOS activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells.

本文引用的文献

1
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.单药伊布替尼治疗复发或难治性滤泡性淋巴瘤:一项 2 期联盟试验。
Blood. 2018 Jan 11;131(2):182-190. doi: 10.1182/blood-2017-09-804641. Epub 2017 Oct 26.
2
The mTOR-Bach2 Cascade Controls Cell Cycle and Class Switch Recombination during B Cell Differentiation.mTOR-Bach2 级联在 B 细胞分化过程中控制细胞周期和类别转换重排。
Mol Cell Biol. 2017 Nov 28;37(24). doi: 10.1128/MCB.00418-17. Print 2017 Dec 15.
3
Reversed graph embedding resolves complex single-cell trajectories.
功能获得性突变驱动 PD-1 ICOS 激活的 T 细胞、滤泡辅助 T 细胞、调节性 T 细胞和滤泡调节性 T 细胞的细胞自主性积累。
Front Immunol. 2023 Mar 7;14:1095257. doi: 10.3389/fimmu.2023.1095257. eCollection 2023.
4
Germinal Centre Shutdown.生发中心衰竭。
Front Immunol. 2021 Jul 7;12:705240. doi: 10.3389/fimmu.2021.705240. eCollection 2021.
5
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.白细胞介素-7 受体信号的激活驱动小鼠 B 细胞急性淋巴细胞白血病。
Leukemia. 2022 Jan;36(1):42-57. doi: 10.1038/s41375-021-01326-x. Epub 2021 Jun 30.
6
Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.Nfkbie 缺陷导致老年小鼠易发生 B 细胞淋巴增殖性疾病。
Blood Cancer J. 2020 Mar 13;10(3):38. doi: 10.1038/s41408-020-0305-6.
7
Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets.弥漫性大B细胞淋巴瘤中细胞存活的失调:机制与治疗靶点
Front Oncol. 2019 Mar 1;9:107. doi: 10.3389/fonc.2019.00107. eCollection 2019.
8
Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.淋巴细胞及弥漫性大B细胞淋巴瘤活化B细胞样亚型中CARMA1-BCL10-MALT1复合物的翻译后修饰
Front Oncol. 2018 Nov 9;8:498. doi: 10.3389/fonc.2018.00498. eCollection 2018.
反向图嵌入解析复杂的单细胞轨迹。
Nat Methods. 2017 Oct;14(10):979-982. doi: 10.1038/nmeth.4402. Epub 2017 Aug 21.
4
Intrinsic Plasma Cell Differentiation Defects in B Cell Expansion with NF-κB and T Cell Anergy Patient B Cells.B细胞因NF-κB和T细胞无能患者B细胞而扩张时的内在浆细胞分化缺陷。
Front Immunol. 2017 Aug 2;8:913. doi: 10.3389/fimmu.2017.00913. eCollection 2017.
5
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.成熟 B 细胞肿瘤中最近鉴定的诊断、预后和预测分子生物标志物的临床实用性。
Mod Pathol. 2017 Oct;30(10):1338-1366. doi: 10.1038/modpathol.2017.58. Epub 2017 Jun 30.
6
Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase.生发中心选择和亲和力成熟需要mTORC1激酶的动态调节。
Immunity. 2017 Jun 20;46(6):1045-1058.e6. doi: 10.1016/j.immuni.2017.06.005.
7
Germline hypomorphic CARD11 mutations in severe atopic disease.严重特应性疾病中的种系低表达CARD11突变
Nat Genet. 2017 Aug;49(8):1192-1201. doi: 10.1038/ng.3898. Epub 2017 Jun 19.
8
Control of B lymphocyte development and functions by the mTOR signaling pathways.mTOR信号通路对B淋巴细胞发育和功能的调控
Cytokine Growth Factor Rev. 2017 Jun;35:47-62. doi: 10.1016/j.cytogfr.2017.04.005. Epub 2017 May 22.
9
ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production.ASCT2(溶质载体家族1成员5)缺陷小鼠的B细胞发育、增殖及抗体产生均正常。
Front Immunol. 2017 May 12;8:549. doi: 10.3389/fimmu.2017.00549. eCollection 2017.
10
Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia.与华氏巨球蛋白血症中依鲁替尼耐药相关的获得性突变。
Blood. 2017 May 4;129(18):2519-2525. doi: 10.1182/blood-2017-01-761726. Epub 2017 Feb 24.